252 related articles for article (PubMed ID: 29364546)
1. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
[TBL] [Abstract][Full Text] [Related]
3. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
[TBL] [Abstract][Full Text] [Related]
4. Impact of Cardiac Implantable Electronic Device Infection: A Clinical and Economic Analysis of the WRAP-IT Trial.
Wilkoff BL; Boriani G; Mittal S; Poole JE; Kennergren C; Corey GR; Love JC; Augostini R; Faerestrand S; Wiggins SS; Healey JS; Holbrook R; Lande JD; Lexcen DR; Willey S; Tarakji KG;
Circ Arrhythm Electrophysiol; 2020 May; 13(5):e008280. PubMed ID: 32281393
[TBL] [Abstract][Full Text] [Related]
5. Health and Economic Outcomes Associated with Use of an Antimicrobial Envelope as a Standard of Care for Cardiac Implantable Electronic Device Implantation.
Shariff N; Eby E; Adelstein E; Jain S; Shalaby A; Saba S; Wang NC; Schwartzman D
J Cardiovasc Electrophysiol; 2015 Jul; 26(7):783-9. PubMed ID: 25845917
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial Envelope Is Associated With Low Infection Rates After Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Replacement: Results of the Citadel and Centurion Studies.
Henrikson CA; Sohail MR; Acosta H; Johnson EE; Rosenthal L; Pachulski R; Dan D; Paladino W; Khairallah FS; Gleed K; Hanna I; Cheng A; Lexcen DR; Simons GR
JACC Clin Electrophysiol; 2017 Oct; 3(10):1158-1167. PubMed ID: 29759500
[TBL] [Abstract][Full Text] [Related]
7. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a Bio-Absorbable Antibacterial Envelope to Prevent Cardiac Implantable Electronic Device Infections in High-Risk Subjects.
Kolek MJ; Patel NJ; Clair WK; Whalen SP; Rottman JN; Kanagasundram A; Shen ST; Saavedra PJ; Estrada JC; Abraham RL; Ellis CR
J Cardiovasc Electrophysiol; 2015 Oct; 26(10):1111-6. PubMed ID: 26222980
[TBL] [Abstract][Full Text] [Related]
9. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.
Polyzos KA; Konstantelias AA; Falagas ME
Europace; 2015 May; 17(5):767-77. PubMed ID: 25926473
[TBL] [Abstract][Full Text] [Related]
11. Proposal for a Novel Score to Determine the Risk of Cardiac Implantable Electronic Device Infection.
Calderón-Parra J; Sánchez-Chica E; Asensio-Vegas Á; Fernández-Lozano I; Toquero-Ramos J; Castro-Urda V; Royuela-Vicente A; Ramos-Martínez A
Rev Esp Cardiol (Engl Ed); 2019 Oct; 72(10):806-812. PubMed ID: 30340923
[TBL] [Abstract][Full Text] [Related]
12. Use of an antibacterial envelope is associated with reduced cardiac implantable electronic device infections in high-risk patients.
Kolek MJ; Dresen WF; Wells QS; Ellis CR
Pacing Clin Electrophysiol; 2013 Mar; 36(3):354-61. PubMed ID: 23252988
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial.
de Oliveira JC; Martinelli M; Nishioka SA; Varejão T; Uipe D; Pedrosa AA; Costa R; D'Avila A; Danik SB
Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):29-34. PubMed ID: 19808441
[TBL] [Abstract][Full Text] [Related]
14. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
[TBL] [Abstract][Full Text] [Related]
15. The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S; Wilkoff BL; Kennergren C; Poole JE; Corey R; Bracke FA; Curnis A; Addo K; Martinez-Arraras J; Issa ZF; Redpath C; Moubarak J; Khelae SK; Boersma LVA; Korantzopoulos P; Krueger J; Lande JD; Morss GM; Seshadri S; Tarakji KG
Heart Rhythm; 2020 Jul; 17(7):1115-1122. PubMed ID: 32087357
[TBL] [Abstract][Full Text] [Related]
16. Strategies to prevent infections associated with cardiovascular implantable electronic devices.
Palraj BR; Farid S; Sohail MR
Expert Rev Med Devices; 2017 May; 14(5):371-381. PubMed ID: 28434261
[TBL] [Abstract][Full Text] [Related]
17. Advances in cardiac implantable electronic device infection prevention: should we push the envelope?
Lambert CT; Wilkoff BL; Tarakji KG
Future Cardiol; 2018 Sep; 14(5):359-366. PubMed ID: 30062906
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the antibacterial envelope to prevent cardiac implantable electronic device infection in a high-risk population.
Chaudhry U; Borgquist R; Smith JG; Mörtsell D
Europace; 2022 Dec; 24(12):1973-1980. PubMed ID: 35989511
[TBL] [Abstract][Full Text] [Related]
19. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study.
Malagù M; Vitali F; Brieda A; Cimaglia P; De Raffele M; Tazzari E; Musolino C; Balla C; Serenelli M; Cultrera R; Rapezzi C; Bertini M
Europace; 2022 Mar; 24(3):413-420. PubMed ID: 34487163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
